Journal of Antimicrobial Chemotherapy (2001) 48, 143-144
© 2001 The British Society for Antimicrobial Chemotherapy
Correspondence |
Dominance of EMRSA-15 and -16 among MRSA causing nosocomial bacteraemia in the UK: analysis of isolates from the European Antimicrobial Resistance Surveillance System (EARSS)
a Antibiotic Resistance Monitoring and Reference Laboratory and b Laboratory of Hospital Infection, Central Public Health Laboratory, 61 Colindale Avenue, London NW9 5HT; c Antimicrobial Susceptibility Surveillance Unit, Queens Medical Centre, Nottingham NG7 2UH, UK
Sir,
The scale of the public health problem posed by methicillin-resistant Staphylococcus aureus (MRSA) in England and Wales increased significantly during the 1990s. Most dramatically, the proportion of cases of S. aureus bacteraemia due to MRSA increased from 1–2% in 1990–1992 to c. 40% in 2000.1–3 This increase coincided with the emergence of two particular epidemic MRSA (EMRSA) strains, EMRSA-15 and EMRSA-16,4 which now dominate MRSA submissions to the S. aureus Reference Service (SaRS) of the Laboratory of Hospital Infection.5 Nevertheless, EMRSA-15 and -16 have not formally been shown to be the principal agents of MRSA bacteraemia in the UK.
Increasing MRSA prevalence rates have also been documented in many other countries. In response to widespread concern about resistance, the European Commission (Directorate General V) has funded pan-European surveillance of resistance. This programme, designated the European Antimicrobial Resistance Surveillance System (EARSS), currently has participants from all countries of the EU, plus Iceland, Norway and Switzerland.6 Since its commencement in late 1998, EARSS has focused on MRSA from nosocomial bacteraemia and penicillin-resistant pneumococci from community-acquired bacteraemia or meningitis. In the participating countries, data are collected from sentinel laboratories by national co-ordinators, then submitted to a central database maintained at the National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands. As methods of susceptibility testing vary between participating laboratories, the laboratories are encouraged, where possible, to obtain MIC data.
In the UK, 26 geographically diverse hospitals are currently submitting data to EARSS. These hospitals record all their S. aureus bacteraemias and send all isolates identified as MRSA to the PHLS Antibiotic Resistance Monitoring and Reference Laboratory (ARMRL) for confirmation of resistance. This is undertaken by the agar incorporation method, and MICs are determined not only for methicillin, but for a range of other antibiotics including vancomycin, teicoplanin, erythromycin, ciprofloxacin, gentamicin, fusidic acid and rifampicin.
Between late 1998 and the second quarter of 2000, 591 MRSA isolates were received by ARMRL under the aegis of EARSS, representing 37% of all S. aureus from bacteraemias reported by the participating laboratories. This prevalence rate is comparable to that among all S. aureus bacteraemias reported to the PHLS over approximately the same period.2,3 Comparative MRSA prevalence data for other countries participating in EARSS can be obtained from the EARSS website.6
All MRSA isolates submitted to ARMRL were additionally characterized by phage typing in the SaRS, which showed that 60.2% were EMRSA-15 and 35.4% were EMRSA-16. Isolates of EMRSA-15 were encountered in 25 of the 26 participating hospitals and EMRSA-16 occurred in 19. Although EMRSA-15 and -16 were already known to occur in many hospitals throughout the UK, our finding that they comprised 95.6% of MRSA from cases of bacteraemia is the first direct confirmation of their predominant role in bloodstream infections. This raises the intriguing question of whether the increase in the prevalence of MRSA bacteraemia reflects greater virulence of EMRSA-15 and -16, or simply that, by virtue of being among the most prevalent S. aureus strains in or on colonized patients, EMRSA-15 and -16 are among the strains most likely to cause endogenous bacteraemia. Further work on the epidemiology and pathogenicity of EMRSA-15 and -16 may give further insight into the success of EMRSA-15 and -16 in invasive disease.
Acknowledgments
The UK EARSS participants include: Dr S. Barrett, Dr D. Brown, Dr P. M. Cockcroft, Dr T. J. Coleman, Dr P. Godwin, Dr K. W. Loudon, Dr J. A. Lowes, Dr L. Macfarlane, Dr N. Manek, Dr P. T. Mannion, G. McAndrew, Dr M. Misra, Dr A. E. Murray, Dr J. Nash, Dr P. B. Nielsen, Dr J. Perry, Dr B. Oapos;Connell, Dr M. S. Osman, Dr H. Panigrahi, Dr R. Parnaby, Dr S. Pugh, Dr P. Rooney, Dr S. Shafi, Dr M. D. Smith, Dr R. C. Spencer, Dr J. Stockley, Dr K. Subesinghe, Dr W. A. Telfer Brunton, Dr N. J.Todd, Dr N. C. Weightman, Dr L. Yee and Dr E. R. Youngs.
Notes
* Corresponding author. Tel: +44-20-8200-4400 ext. 4237; Fax: +44-20-8358-3292; E-mail: ajohnson{at}phls.nhs.uk 
The UK EARSS participants are listed in the Acknowledgements.
References
1 . Speller, D. C. E., Johnson, A. P., James, D., Marples, R. R., Charlett, A. & George, R. C. (1997). Resistance to methicillin and other antibiotics of Staphylococcus aureus from blood and cerebrospinal fluid, England and Wales, 1989–1995. Lancet 350, 323–5.[Web of Science][Medline]
2
.
Reacher, M. H., Shah, A., Livermore, D. M., Wale, M. C., Graham, C., Johnson, A. P. et al. (2000). Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis. British Medical Journal 320, 213–6.
3 . Public Health Laboratory Service. (2000). Staphylococcus aureus bacteraemia: England and Wales, January to December 1999. Communicable Disease Report 10, 23–4.
4 . Combined Working Party of the British Society for Antimicrobial Chemotherapy, the Hospital Infection Society and the Infection Control Nurses Association. (1998). Revised guidelines for the control of methicillin-resistant Staphylococcus aureus infection in hospitals. Journal of Hospital Infection 39, 253–90.[Web of Science][Medline]
5 . PHLS website. [On-line.] http://www.phls.co.uk (16 January 2001, date last accessed).
6 . EARSS website. Copyright 2000. Published by RIVM. [On-line.] http://www.earss.rivm.nl (16 January 2001, date last accessed).
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. S. Soliman, G. Phillips, P. Whitty, and D. H. Edwards Distribution of meticillin-resistant Staphylococcus aureus spa types isolated from health-care workers and patients in a Scottish university teaching hospital J. Med. Microbiol., September 1, 2009; 58(9): 1190 - 1195. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Whittaker, R. E. Warren, R. S. Jones, and P. A. Gregson Is prolonged systemic antibiotic treatment essential in two-stage revision hip replacement for chronic Gram-positive infection? J Bone Joint Surg Br, January 1, 2009; 91-B(1): 44 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Livermore Future directions with daptomycin J. Antimicrob. Chemother., November 1, 2008; 62(suppl_3): iii41 - iii49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Aires-de-Sousa, B. Correia, H. de Lencastre, and and the Multilaboratory Project Collaborators Changing Patterns in Frequency of Recovery of Five Methicillin-Resistant Staphylococcus aureus Clones in Portuguese Hospitals: Surveillance over a 16-Year Period J. Clin. Microbiol., September 1, 2008; 46(9): 2912 - 2917. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Smith, A. Perez, G. Ramage, D. Lappin, C. G. Gemmell, and S. Lang Biofilm formation by Scottish clinical isolates of Staphylococcus aureus J. Med. Microbiol., August 1, 2008; 57(8): 1018 - 1023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B V S Krishna, M Smith, A McIndeor, A P Gibb, and J Dave Evaluation of Chromogenic MRSA medium, MRSASelect and Oxacillin Resistance Screening Agar for the detection of methicillin-resistant Staphylococcus aureus J. Clin. Pathol., July 1, 2008; 61(7): 841 - 843. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Feil, E. K. Nickerson, N. Chantratita, V. Wuthiekanun, P. Srisomang, R. Cousins, W. Pan, G. Zhang, B. Xu, N. P. J. Day, et al. Rapid Detection of the Pandemic Methicillin-Resistant Staphylococcus aureus Clone ST 239, a Dominant Strain in Asian Hospitals J. Clin. Microbiol., April 1, 2008; 46(4): 1520 - 1522. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Larsen, R. L. Skov, V. Jarlier, and A. S. Henriksen Epidemiological differences between the UK and Ireland versus France in Staphylococcus aureus isolates resistant to fusidic acid from community-acquired skin and soft tissue infections J. Antimicrob. Chemother., March 1, 2008; 61(3): 589 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. L. Amorim, N. A. Faria, D. C. Oliveira, C. Vasconcelos, J. C. Cabeda, A. C. Mendes, E. Calado, A. P. Castro, M. H. Ramos, J. M. Amorim, et al. Changes in the Clonal Nature and Antibiotic Resistance Profiles of Methicillin-Resistant Staphylococcus aureus Isolates Associated with Spread of the EMRSA-15 Clone in a Tertiary Care Portuguese Hospital J. Clin. Microbiol., September 1, 2007; 45(9): 2881 - 2888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Holtfreter, D. Grumann, M. Schmudde, H. T. T. Nguyen, P. Eichler, B. Strommenger, K. Kopron, J. Kolata, S. Giedrys-Kalemba, I. Steinmetz, et al. Clonal Distribution of Superantigen Genes in Clinical Staphylococcus aureus Isolates J. Clin. Microbiol., August 1, 2007; 45(8): 2669 - 2680. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Livermore The zeitgeist of resistance J. Antimicrob. Chemother., August 1, 2007; 60(suppl_1): i59 - i61. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Moodley, M. Stegger, A. F. Bagcigil, K. E. Baptiste, A. Loeffler, D. H. Lloyd, N. J. Williams, N. Leonard, Y. Abbott, R. Skov, et al. spa typing of methicillin-resistant Staphylococcus aureus isolated from domestic animals and veterinary staff in the UK and Ireland J. Antimicrob. Chemother., December 1, 2006; 58(6): 1118 - 1123. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. X. Ma, T. Ito, P. Chongtrakool, and K. Hiramatsu Predominance of Clones Carrying Panton-Valentine Leukocidin Genes among Methicillin-Resistant Staphylococcus aureus Strains Isolated in Japanese Hospitals from 1979 to 1985 J. Clin. Microbiol., December 1, 2006; 44(12): 4515 - 4527. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. G. Gemmell, D. I. Edwards, A. P. Fraise, F. K. Gould, G. L. Ridgway, R. E. Warren, and on behalf of the Joint Working Party of the Britis Guidelines for the prophylaxis and treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in the UK J. Antimicrob. Chemother., April 1, 2006; 57(4): 589 - 608. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wisplinghoff, B. Ewertz, S. Wisplinghoff, D. Stefanik, G. Plum, F. Perdreau-Remington, and H. Seifert Molecular Evolution of Methicillin-Resistant Staphylococcus aureus in the Metropolitan Area of Cologne, Germany, from 1984 to 1998 J. Clin. Microbiol., November 1, 2005; 43(11): 5445 - 5451. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Loeffler, A. K. Boag, J. Sung, J. A. Lindsay, L. Guardabassi, A. Dalsgaard, H. Smith, K. B. Stevens, and D. H. Lloyd Prevalence of methicillin-resistant Staphylococcus aureus among staff and pets in a small animal referral hospital in the UK J. Antimicrob. Chemother., October 1, 2005; 56(4): 692 - 697. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Johnson, A. Pearson, and G. Duckworth Surveillance and epidemiology of MRSA bacteraemia in the UK J. Antimicrob. Chemother., September 1, 2005; 56(3): 455 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. B. Wannet, E. Spalburg, M. E. O. C. Heck, G. N. Pluister, E. Tiemersma, R. J. L. Willems, X. W. Huijsdens, A. J. de Neeling, and J. Etienne Emergence of Virulent Methicillin-Resistant Staphylococcus aureus Strains Carrying Panton-Valentine Leucocidin Genes in The Netherlands J. Clin. Microbiol., July 1, 2005; 43(7): 3341 - 3345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Cassat, P. M. Dunman, F. McAleese, E. Murphy, S. J. Projan, and M. S. Smeltzer Comparative Genomics of Staphylococcus aureus Musculoskeletal Isolates J. Bacteriol., January 15, 2005; 187(2): 576 - 592. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Saunders, A. Underwood, A. M. Kearns, and G. Hallas A virulence-associated gene microarray: a tool for investigation of the evolution and pathogenic potential of Staphylococcus aureus Microbiology, November 1, 2004; 150(11): 3763 - 3771. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Perez-Roth, F. Lorenzo-Diaz, N. Batista, A. Moreno, and S. Mendez-Alvarez Tracking Methicillin-Resistant Staphylococcus aureus Clones during a 5-Year Period (1998 to 2002) in a Spanish Hospital J. Clin. Microbiol., October 1, 2004; 42(10): 4649 - 4656. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. B. Wannet, E. Spalburg, M. E. O. C. Heck, G. N. Pluister, R. J. L. Willems, and A. J. de Neeling Widespread Dissemination in The Netherlands of the Epidemic Berlin Methicillin-Resistant Staphylococcus aureus Clone with Low-Level Resistance to Oxacillin J. Clin. Microbiol., July 1, 2004; 42(7): 3077 - 3082. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. T. G. Holden, E. J. Feil, J. A. Lindsay, S. J. Peacock, N. P. J. Day, M. C. Enright, T. J. Foster, C. E. Moore, L. Hurst, R. Atkin, et al. Complete genomes of two clinical Staphylococcus aureus strains: Evidence for the rapid evolution of virulence and drug resistance PNAS, June 29, 2004; 101(26): 9786 - 9791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Reynolds, N. Potz, M. Colman, A. Williams, D. Livermore, A. MacGowan, and on behalf of the BSAC Extended Working Party on Ba Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC Bacteraemia Resistance Surveillance Programme J. Antimicrob. Chemother., June 1, 2004; 53(6): 1018 - 1032. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Hardy, P. M. Hawkey, F. Gao, and B. A. Oppenheim Methicillin resistant Staphylococcus aureus in the critically ill Br. J. Anaesth., January 1, 2004; 92(1): 121 - 130. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Harmsen, H. Claus, W. Witte, J. Rothganger, H. Claus, D. Turnwald, and U. Vogel Typing of Methicillin-Resistant Staphylococcus aureus in a University Hospital Setting by Using Novel Software for spa Repeat Determination and Database Management J. Clin. Microbiol., December 1, 2003; 41(12): 5442 - 5448. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Okuma, K. Iwakawa, J. D. Turnidge, W. B. Grubb, J. M. Bell, F. G. O'Brien, G. W. Coombs, J. W. Pearman, F. C. Tenover, M. Kapi, et al. Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community J. Clin. Microbiol., November 1, 2002; 40(11): 4289 - 4294. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. M. Aucken, M. Ganner, S. Murchan, B. D. Cookson, and A. P. Johnson A new UK strain of epidemic methicillin-resistant Staphylococcus aureus (EMRSA-17) resistant to multiple antibiotics J. Antimicrob. Chemother., August 1, 2002; 50(2): 171 - 175. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Johnson, M. Warner, and D. M. Livermore In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci J. Antimicrob. Chemother., July 1, 2002; 50(1): 89 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. C. Oliveira and H. d. Lencastre Multiplex PCR Strategy for Rapid Identification of Structural Types and Variants of the mec Element in Methicillin-Resistant Staphylococcus aureus Antimicrob. Agents Chemother., July 1, 2002; 46(7): 2155 - 2161. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P.C. L. MOORE and J.A. LINDSAY Molecular characterisation of the dominant UK methicillin-resistant Staphylococcus aureus strains, EMRSA-15 and EMRSA-16 J. Med. Microbiol., June 1, 2002; 51(6): 516 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Johnson, M. Warner, M. Carter, and D. M. Livermore In Vitro Activity of Cephalosporin RWJ-54428 (MC-02479) against Multidrug-Resistant Gram-Positive Cocci Antimicrob. Agents Chemother., February 1, 2002; 46(2): 321 - 326. [Abstract] [Full Text] [PDF]
|
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||